# Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects

> **NCT04361630** · EARLY_PHASE1 · COMPLETED · sponsor: **SVS Institute of Dental Sciences** · enrollment: 30 (actual)

## Conditions studied

- Periodontitis

## Interventions

- **DRUG:** FGF 2

## Key facts

- **NCT ID:** NCT04361630
- **Lead sponsor:** SVS Institute of Dental Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04361630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04361630, "Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04361630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*